玻璃体内注射贝伐单抗治疗后囊膜新生血管形成。
Intravitreal bevacizumab for posterior capsule neovascularization.
作者信息
Al-Mohaimeed Mansour, Al-Gehedan Saeed, Dhibi Hassan Al
机构信息
College of Medicine, Al-Qassim University, Al-Qassim, P.O. Box 6655, Buraidah 51452, Saudi Arabia.
出版信息
Saudi J Ophthalmol. 2010 Apr;24(2):63-5. doi: 10.1016/j.sjopt.2010.02.002. Epub 2010 Apr 2.
Abstract
We report a case of rapid regression of extensive posterior capsule neovascularization in a 67-year-old diabetic male patient, who developed posterior capsule opacity with neovascularization one year post cataract surgery, after a single injection of intravitreal bevacizumab (Avastin) followed by neodymium:YAG capsulotomy. Rapid regression of the posterior capsule neovascularization, and visual improvement was observed 9 days after the intervention. Posterior capsulotomy was performed successfully without bleeding. Prior to posterior capsulotomy, intravitreal bevacizumab can result in rapid and dramatic regression of posterior capsule neovascularization.
摘要
我们报告了一例67岁糖尿病男性患者广泛后囊膜新生血管快速消退的病例。该患者在白内障手术后一年出现后囊膜混浊并伴有新生血管，在单次玻璃体内注射贝伐单抗（阿瓦斯汀）后行钕:钇铝石榴石激光后囊膜切开术。干预后9天观察到后囊膜新生血管快速消退且视力改善。后囊膜切开术成功实施，无出血。在进行后囊膜切开术之前，玻璃体内注射贝伐单抗可导致后囊膜新生血管快速且显著消退。
相似文献
1
Intravitreal bevacizumab for posterior capsule neovascularization.玻璃体内注射贝伐单抗治疗后囊膜新生血管形成。
Saudi J Ophthalmol. 2010 Apr;24(2):63-5. doi: 10.1016/j.sjopt.2010.02.002. Epub 2010 Apr 2.
2
Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy.
Clin Ophthalmol. 2008 Sep;2(3):657-60. doi: 10.2147/opth.s2686.
3
Regression of neovascular posterior capsule vessels by intravitreal bevacizumab.玻璃体内注射贝伐单抗使新生血管性后囊膜血管消退。
J Cataract Refract Surg. 2007 Jun;33(6):1113-5. doi: 10.1016/j.jcrs.2007.01.040.
4
Posterior lens capsule neovascularization treated with anti-VEGF complicated by phacogenic uveitis.抗血管内皮生长因子治疗后发性晶状体囊膜新生血管化并发晶状体源性葡萄膜炎。
Am J Ophthalmol Case Rep. 2020 Oct 3;20:100943. doi: 10.1016/j.ajoc.2020.100943. eCollection 2020 Dec.
5
Intravitreal Bevacizumab for Inflammatory Neovascularization of the Lens after Traumatic Open Globe Injury.眼内注射贝伐单抗治疗外伤性开放性眼球损伤后晶状体炎性新生血管。
Ocul Immunol Inflamm. 2020 May 18;28(4):699-702. doi: 10.1080/09273948.2019.1609048. Epub 2019 Jul 3.
6
Posterior capsule opacity and choroidal neovascularization in patients with age-related macular degeneration.年龄相关性黄斑变性患者的后囊膜混浊与脉络膜新生血管形成
Ophthalmic Surg Lasers Imaging. 2006 Jan-Feb;37(1):20-4.
7
8
Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗增殖性糖尿病视网膜病变合并玻璃体积血。
Retina. 2006 Mar;26(3):275-8. doi: 10.1097/00006982-200603000-00004.
9
Rapid regression of extensive retinovitreal neovascularization secondary to branch retinal vein occlusion after a single intravitreal injection of bevacizumab.玻璃体内单次注射贝伐单抗后，继发于视网膜分支静脉阻塞的广泛视网膜玻璃体新生血管迅速消退。
Int Ophthalmol. 2005 Aug-Oct;26(4-5):191-3. doi: 10.1007/s10792-007-9036-y. Epub 2007 Feb 8.
10
Neovascular glaucoma following neodymium-YAG laser posterior capsulotomy.钕钇铝石榴石激光后囊切开术后新生血管性青光眼
Arch Ophthalmol. 1986 May;104(5):730-1. doi: 10.1001/archopht.1986.01050170120035.
引用本文的文献
1
Posterior lens capsule neovascularization treated with anti-VEGF complicated by phacogenic uveitis.抗血管内皮生长因子治疗后发性晶状体囊膜新生血管化并发晶状体源性葡萄膜炎。
Am J Ophthalmol Case Rep. 2020 Oct 3;20:100943. doi: 10.1016/j.ajoc.2020.100943. eCollection 2020 Dec.
本文引用的文献
1
Photodynamic therapy for posterior capsule neovascularization.后囊膜新生血管的光动力疗法。
J Cataract Refract Surg. 2007 Jun;33(6):1131-2. doi: 10.1016/j.jcrs.2007.02.025.
2
Regression of neovascular posterior capsule vessels by intravitreal bevacizumab.玻璃体内注射贝伐单抗使新生血管性后囊膜血管消退。
J Cataract Refract Surg. 2007 Jun;33(6):1113-5. doi: 10.1016/j.jcrs.2007.01.040.
3
Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗新生血管性青光眼眼前段新生血管的短期疗效
Acta Ophthalmol Scand. 2006 Aug;84(4):556-7. doi: 10.1111/j.1600-0420.2006.00731.x.
4
Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.玻璃体内注射贝伐单抗用于治疗年龄相关性黄斑变性中的脉络膜新生血管。
Am J Ophthalmol. 2006 Jul;142(1):1-9. doi: 10.1016/j.ajo.2006.02.037.
5
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.玻璃体腔内注射贝伐单抗治疗年龄相关性黄斑变性继发脉络膜新生血管
Retina. 2006 Apr;26(4):383-90. doi: 10.1097/01.iae.0000238561.99283.0e.
6
Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection.单次注射贝伐单抗（阿瓦斯汀）后虹膜新生血管迅速改善。
Retina. 2006 Mar;26(3):354-6. doi: 10.1097/00006982-200603000-00017.
7
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗后视网膜和虹膜新生血管的消退。
Retina. 2006 Mar;26(3):352-4. doi: 10.1097/00006982-200603000-00016.
8
Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗增殖性糖尿病视网膜病变合并玻璃体积血。
Retina. 2006 Mar;26(3):275-8. doi: 10.1097/00006982-200603000-00004.
9
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗新生血管性年龄相关性黄斑变性。
Ophthalmology. 2006 Mar;113(3):363-372.e5. doi: 10.1016/j.ophtha.2005.11.019. Epub 2006 Feb 3.
10
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.玻璃体内注射贝伐单抗（阿瓦斯汀）治疗视网膜中央静脉阻塞所致黄斑水肿后的光学相干断层扫描结果
Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):336-9.
Zotero 插件